Portfolio Holdings Detail for ISIN IE0003WV2ME7
Stock Name / Fund iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF Ticker ISPE(GBP) LSE
ETF Ticker ISPE.L(GBP) LSE

Holdings detail for REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

Show aggregate REGN holdings

News associated with REGN

Regeneron And Sanofi : CHMP Recommends EU Approval Of Dupixent For Chronic Spontaneous Urticaria: (RTTNews) - Regeneron Pharmaceuticals Inc. (REGN) and Sanofi announced that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP has adopted a positive opinion recommending the approval of Dupixent (dupilumab) in the European Union for treating c - 2025-09-22 02:12:20
Peek Under The Hood: JEPQ Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-08 08:26:56
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Given Consensus Rating of “Moderate Buy” by Brokerages: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-six analysts that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, six have issued a hold rating, sixteen have assigned a buy rating and three […] - 2025-08-26 02:16:48
LABU, INCY, UTHR, REGN: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily S&P Biotech Bull 3x Shares (Symbol: LABU) where we have detected an approximate $67.3 million dollar outflow -- that's a 9.4% dec - 2025-08-20 12:04:03
Regeneron Pharmaceuticals (NASDAQ:REGN) versus Cadrenal Therapeutics (NASDAQ:CVKD) Head-To-Head Analysis: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) and Cadrenal Therapeutics (NASDAQ:CVKD – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability and earnings. Volatility and Risk Regeneron Pharmaceuticals has a beta […] - 2025-08-20 02:22:48
Truist Financial Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $812.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target reduced by Truist Financial from $940.00 to $812.00 in a research note published on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of several other reports. The Goldman Sachs Group dropped their price target on […] - 2025-08-14 03:00:52
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Position Raised by Blair William & Co. IL: Blair William & Co. IL lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.2% in the 1st quarter, Holdings Channel reports. The fund owned 1,282 shares of the biopharmaceutical company’s stock after buying an additional 27 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth […] - 2025-08-11 06:26:50
Harbour Investments Inc. Sells 32 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Harbour Investments Inc. reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 7.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 403 shares of the biopharmaceutical company’s stock after selling 32 shares during the quarter. Harbour Investments Inc.’s holdings in […] - 2025-08-07 09:40:47
We Did The Math SPYX Can Go To $58: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-07 08:58:54
409 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Purchased by Arkadios Wealth Advisors: Arkadios Wealth Advisors purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 409 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. Several other institutional investors and hedge funds also […] - 2025-08-07 05:38:53
Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price Expected to Rise, BMO Capital Markets Analyst Says: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target upped by stock analysts at BMO Capital Markets from $600.00 to $640.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 12.30% from […] - 2025-08-06 03:12:48
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $828.86 Consensus Target Price from Brokerages: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-four ratings firms that are currently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, fifteen have assigned a buy recommendation and two […] - 2025-08-04 02:59:01
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 19:31:54
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:40:40
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:35:36
Stocks Slump on Tariffs and Weak US Job Growth: The S&P 500 Index ($SPX ) (SPY ) today is down -1.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.01%. September E-mini S&P futures (ESU25 ) are down -1.75%, and September E-mini Nasdaq futures... - 2025-08-01 14:02:25
Nasdaq 100 Movers: MRVL, REGN: In early trading on Friday, shares of Regeneron Pharmaceuticals, topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.6%. Year to date, Regeneron Pharmaceuticals, has lost about 20.7% of its value. And the worst performing Nasdaq 100 co - 2025-08-01 11:30:09
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Choreo LLC: Choreo LLC boosted its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 0.9% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,746 shares of the biopharmaceutical company’s stock after acquiring an additional 32 shares during the period. Choreo LLC’s holdings in Regeneron Pharmaceuticals […] - 2025-07-24 07:22:56
Crestwood Advisors Group LLC Grows Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Crestwood Advisors Group LLC increased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 467 shares of the biopharmaceutical company’s stock after purchasing an additional 25 shares during the quarter. Crestwood Advisors Group […] - 2025-07-24 05:47:12
Kestra Private Wealth Services LLC Has $1.31 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Kestra Private Wealth Services LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,058 shares of the biopharmaceutical company’s stock after buying an additional 132 shares during the quarter. […] - 2025-07-23 07:50:58
Larson Financial Group LLC Has $34,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Larson Financial Group LLC lessened its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53 shares of the biopharmaceutical company’s stock after selling 28 shares during the quarter. Larson […] - 2025-07-23 06:30:53
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Purchased by Alps Advisors Inc.: Alps Advisors Inc. raised its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 71.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 530 shares of the biopharmaceutical company’s stock after purchasing an additional 220 shares during the quarter. Alps Advisors Inc.’s […] - 2025-07-17 05:50:54
Stratos Wealth Partners LTD. Sells 115 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Stratos Wealth Partners LTD. trimmed its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 18.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 506 shares of the biopharmaceutical company’s stock after selling 115 shares during the period. Stratos Wealth Partners […] - 2025-07-16 04:58:54
Allworth Financial LP Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Allworth Financial LP trimmed its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 821 shares of the biopharmaceutical company’s stock after selling 137 shares during the period. Allworth Financial […] - 2025-07-15 08:20:00
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $584.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target increased by UBS Group from $560.00 to $584.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts also recently commented on REGN. BMO Capital Markets reduced their price objective on Regeneron […] - 2025-07-14 03:30:48
Brown Advisory Inc. Reduces Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Brown Advisory Inc. lowered its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,269 shares of the biopharmaceutical company’s stock after selling 247 shares during the quarter. Brown Advisory Inc.’s […] - 2025-07-13 05:54:54
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Cut by D.A. Davidson & CO.: D.A. Davidson & CO. reduced its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 732 shares of the biopharmaceutical company’s stock after selling 21 shares during the quarter. D.A. […] - 2025-07-11 05:32:52
Brokerages Set Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) PT at $813.57: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, fifteen have assigned a buy rating and three have issued […] - 2025-07-10 03:07:00
DAVENPORT & Co LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): DAVENPORT & Co LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 427 shares of the biopharmaceutical company’s stock, valued at approximately $271,000. A number of other institutional […] - 2025-07-09 05:11:22
Bessemer Group Inc. Sells 3,860 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Bessemer Group Inc. decreased its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 76.0% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,218 shares of the biopharmaceutical company’s stock after selling 3,860 shares during the period. Bessemer Group […] - 2025-07-01 05:46:52

iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc) REGN holdings

Date	Number of REGN Shares Held	Base Market Value of REGN Shares	Local Market Value of REGN Shares	Change in REGN Shares Held	Change in REGN Base Value	Current Price per REGN Share Held	Previous Price per REGN Share Held
2025-12-03 (Wednesday)	14,403	USD 10,423,019	USD 10,423,019	40	USD -234,327	USD 723.67	USD 742
2025-12-02 (Tuesday)	14,363	USD 10,657,346	USD 10,657,346	0	USD -116,484	USD 742	USD 750.11
2025-12-01 (Monday)	14,363	USD 10,773,830	USD 10,773,830	160	USD -369,986	USD 750.11	USD 784.61
2025-11-27 (Thursday)	14,203	USD 11,143,816	USD 11,143,816	180	USD 543,830	USD 784.61	USD 755.9
2025-11-21 (Friday)	14,023	USD 10,599,986	USD 10,599,986	20	USD 279,775	USD 755.9	USD 737
2025-11-20 (Thursday)	14,003	USD 10,320,211	USD 10,320,211	0	USD 163,275	USD 737	USD 725.34
2025-11-18 (Tuesday)	14,003	USD 10,156,936	USD 10,156,936	0	USD 294,483	USD 725.34	USD 704.31
2025-11-17 (Monday)	14,003	USD 9,862,453	USD 9,862,453	0	USD 151,372	USD 704.31	USD 693.5

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of REGN by Blackrock for IE0003WV2ME7

Show aggregate share trades of REGN

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-03 BUY 40 744.225 720.140 722.549 USD 28,902 650.44
2025-12-01 BUY 160 779.840 748.210 751.373 USD 120,220 649.62
2025-11-27 BUY 180 784.610* 649.04
2025-11-21 BUY 20 755.900* 648.58
2025-11-11 SELL -10 676.330 651.410 653.902 USD -6,539 647.14 Loss of -68 on sale
2025-11-07 BUY 70 657.530* 647.05
2025-11-05 SELL -680 646.895 628.000 629.890 USD -428,325 647.07 Profit of 11,682 on sale
2025-10-29 SELL -538 652.910 659.980 659.273 USD -354,689 647.10 Loss of -6,550 on sale
2025-10-24 SELL -110 577.950 582.700 582.225 USD -64,045 647.68 Profit of 7,200 on sale
2025-10-23 SELL -20 575.690 584.000 583.169 USD -11,663 648.02 Profit of 1,297 on sale
2025-10-22 BUY 30 584.740 588.710 588.313 USD 17,649 648.32
2025-10-20 SELL -350 576.770 582.650 582.062 USD -203,722 648.99 Profit of 23,425 on sale
2025-10-16 SELL -50 569.170 589.080 587.089 USD -29,354 649.37 Profit of 3,114 on sale
2025-10-15 SELL -125 576.420 584.870 584.025 USD -73,003 649.73 Profit of 8,213 on sale
2025-10-03 BUY 40 600.000 618.010 616.209 USD 24,648 650.66
2025-10-02 SELL -400 600.000 605.410 604.869 USD -241,948 650.91 Profit of 18,417 on sale
2025-10-01 SELL -383 599.940 615.390 613.845 USD -235,103 651.16 Profit of 14,293 on sale
2025-09-30 SELL -10 562.270 574.040 572.863 USD -5,729 651.61 Profit of 787 on sale
2025-09-29 SELL -132 560.750 564.910 564.494 USD -74,513 652.06 Profit of 11,559 on sale
2025-09-26 SELL -10 563.900 564.610 564.539 USD -5,645 652.50 Profit of 880 on sale
2025-09-25 BUY 130 555.510 579.000 576.651 USD 74,965 652.99
2025-09-24 SELL -88 576.980 577.980 577.880 USD -50,853 653.38 Profit of 6,644 on sale
2025-09-18 BUY 20 598.710 600.000 599.871 USD 11,997 653.66
2025-08-18 BUY 18 573.910 585.000 583.891 USD 10,510 655.26
2025-08-12 SELL -10 556.550 562.740 562.121 USD -5,621 657.16 Profit of 950 on sale
2025-07-31 SELL -411 545.460 558.130 556.863 USD -228,871 657.75 Profit of 41,467 on sale
2025-07-29 BUY 11 558.150 559.610 559.464 USD 6,154 658.85
2025-07-23 SELL -30 572.390 576.700 576.269 USD -17,288 660.39 Profit of 2,524 on sale
2025-07-22 SELL -60 560.930 563.000 562.793 USD -33,768 660.94 Profit of 5,889 on sale
2025-07-21 SELL -20 545.530 552.980 552.235 USD -11,045 661.58 Profit of 2,187 on sale
2025-07-15 SELL -20 547.960 574.750 572.071 USD -11,441 662.86 Profit of 1,816 on sale
2025-07-14 SELL -50 570.590 575.130 574.676 USD -28,734 663.38 Profit of 4,435 on sale
2025-07-11 SELL -30 567.740 568.460 568.388 USD -17,052 663.93 Profit of 2,866 on sale
2025-07-10 SELL -120 559.760 566.370 565.709 USD -67,885 664.52 Profit of 11,858 on sale
2025-07-09 SELL -40 552.580 558.380 557.800 USD -22,312 665.17 Profit of 4,295 on sale
2025-07-08 SELL -130 547.750 559.460 558.289 USD -72,578 665.84 Profit of 13,982 on sale
2025-07-03 SELL -170 547.360 555.000 554.236 USD -94,220 667.99 Profit of 19,338 on sale
2025-07-02 SELL -31 547.740 551.500 551.124 USD -17,085 668.70 Profit of 3,645 on sale
2025-06-30 BUY 446 525.000 526.080 525.972 USD 234,584 669.56
2025-06-27 SELL -490 521.000 531.210 530.189 USD -259,793 670.45 Profit of 68,726 on sale
2025-06-25 BUY 10 520.290 525.630 525.096 USD 5,251 672.26
2025-06-24 SELL -370 522.270 527.450 526.932 USD -194,965 673.18 Profit of 54,110 on sale
2025-06-23 SELL -10 511.920 516.180 515.754 USD -5,158 674.17 Profit of 1,584 on sale
2025-06-20 BUY 5,426 509.720 521.310 520.151 USD 2,822,339 675.18
2025-06-18 SELL -42 513.580 519.170 518.611 USD -21,782 677.20 Profit of 6,661 on sale
2025-06-17 SELL -77 508.860 523.010 521.595 USD -40,163 678.26 Profit of 12,063 on sale
2025-06-11 SELL -21 518.600 528.370 527.393 USD -11,075 680.27 Profit of 3,210 on sale
2025-06-10 SELL -49 523.530 529.990 529.344 USD -25,938 681.28 Profit of 7,445 on sale
2025-06-06 SELL -14 493.220 499.880 499.214 USD -6,989 683.56 Profit of 2,581 on sale
2025-06-05 SELL -119 483.070 491.770 490.900 USD -58,417 684.87 Profit of 23,083 on sale
2025-06-02 SELL -567 490.810 502.560 501.385 USD -284,285 688.81 Profit of 106,271 on sale
2025-05-30 SELL -126 490.280 519.780 516.830 USD -65,121 690.14 Profit of 21,838 on sale
2025-05-29 SELL -14 605.390 605.730 605.696 USD -8,480 690.72 Profit of 1,190 on sale
2025-05-27 SELL -14 603.260 608.170 607.679 USD -8,508 691.99 Profit of 1,180 on sale
2025-05-23 SELL -21 588.340 591.640 591.310 USD -12,418 693.43 Profit of 2,145 on sale
2025-05-16 SELL -105 594.320 595.190 595.103 USD -62,486 696.74 Profit of 10,672 on sale
2025-05-15 SELL -21 584.990 585.260 585.233 USD -12,290 697.55 Profit of 2,359 on sale
2025-05-13 SELL -7 574.160 575.050 574.961 USD -4,025 699.39 Profit of 871 on sale
2025-05-12 SELL -49 575.630 577.990 577.754 USD -28,310 700.30 Profit of 6,005 on sale
2025-05-09 SELL -42 527.780 552.840 550.334 USD -23,114 701.59 Profit of 6,353 on sale
2025-05-08 SELL -203 547.670 552.570 552.080 USD -112,072 702.75 Profit of 30,586 on sale
2025-05-07 SELL -14 560.930 568.130 567.410 USD -7,944 703.82 Profit of 1,910 on sale
2025-05-06 BUY 8 558.520 606.870 602.035 USD 4,816 704.93
2025-05-01 BUY 266 590.000 593.930 593.537 USD 157,881 707.40
2025-04-30 BUY 147 598.760 600.200 600.056 USD 88,208 708.25
2025-04-29 SELL -28 568.910 579.980 578.873 USD -16,208 709.36 Profit of 3,654 on sale
2025-04-28 SELL -35 610.860 614.830 614.433 USD -21,505 710.15 Profit of 3,350 on sale
2025-04-25 BUY 14 602.640 602.790 602.775 USD 8,439 711.01
2025-04-24 SELL -7 599.760 601.280 601.128 USD -4,208 711.92 Profit of 776 on sale
2025-04-22 SELL -938 585.490 587.100 586.939 USD -550,549 713.99 Profit of 119,173 on sale
2025-04-17 SELL -427 563.160 564.210 564.105 USD -240,873 717.84 Profit of 65,644 on sale
2025-04-16 BUY 14 549.280 561.830 560.575 USD 7,848 719.28
2025-04-15 BUY 14 557.910 575.200 573.471 USD 8,029 720.67
2025-04-10 SELL -441 546.390 571.990 569.430 USD -251,119 725.01 Profit of 68,610 on sale
2025-04-09 BUY 35 576.720 580.730 580.329 USD 20,312 726.33
2025-04-08 BUY 7 556.810 586.030 583.108 USD 4,082 727.86
2025-04-07 BUY 126 572.780 591.540 589.664 USD 74,298 729.27
2025-04-04 BUY 77 573.450 612.990 609.036 USD 46,896 730.70
2025-04-02 BUY 49 625.600 628.000 627.760 USD 30,760 731.67
2025-04-01 BUY 553 617.000 641.240 638.816 USD 353,265 732.74
2025-03-31 BUY 21 634.230 640.720 640.071 USD 13,441 733.67
2025-03-25 BUY 7 634.140 662.570 659.727 USD 4,618 737.47
2025-03-21 BUY 578 658.480 661.000 660.748 USD 381,912 739.02
2025-03-20 BUY 14 662.620 674.830 673.609 USD 9,431 739.80
2025-03-18 BUY 35 664.960 678.270 676.939 USD 23,693 741.26
2025-03-17 BUY 7 678.420 679.830 679.689 USD 4,758 741.92
2025-03-13 SELL -420 680.610 698.950 697.116 USD -292,789 743.37 Profit of 19,426 on sale
2025-03-12 BUY 84 689.500 712.460 710.164 USD 59,654 743.95
2025-03-11 BUY 84 718.160 747.700 744.746 USD 62,559 744.23
2025-03-07 BUY 28 707.510 729.750 727.526 USD 20,371 744.63
2025-03-06 BUY 98 698.440 701.000 700.744 USD 68,673 745.15
2025-03-05 BUY 532 687.150 692.790 692.226 USD 368,264 745.81
2025-03-04 BUY 28 675.490 697.460 695.263 USD 19,467 746.62
2025-03-03 BUY 35 684.870 704.640 702.663 USD 24,593 747.33
2025-02-28 BUY 70 698.740 708.580 707.596 USD 49,532 747.91
2025-02-27 BUY 63 702.780 721.000 719.178 USD 45,308 748.44
2025-02-26 SELL -35 706.940 721.410 719.963 USD -25,199 748.94 Profit of 1,014 on sale
2025-02-25 SELL -7 723.470 739.000 737.447 USD -5,162 749.25 Profit of 83 on sale
2025-02-24 BUY 7 713.250 725.000 723.825 USD 5,067 749.70
2025-02-20 SELL -91 696.020 703.140 702.428 USD -63,921 751.00 Profit of 4,420 on sale
2025-02-19 BUY 28 685.660 688.670 688.369 USD 19,274 751.84
2025-02-18 BUY 28 680.000 689.950 688.955 USD 19,291 752.77
2025-02-13 BUY 798 674.270 677.690 677.348 USD 540,524 755.97
2025-02-12 BUY 238 663.860 670.980 670.268 USD 159,524 757.24
2025-02-11 BUY 196 665.460 680.790 679.257 USD 133,134 758.51
2025-02-07 BUY 21 710.000 731.420 729.278 USD 15,315 760.18
2025-02-06 BUY 280 722.070 734.270 733.050 USD 205,254 760.73
2025-02-05 BUY 140 716.720 729.250 727.997 USD 101,920 761.38
2025-02-04 BUY 105 697.050 709.980 708.687 USD 74,412 762.34
2025-02-03 SELL -609 666.850 673.650 672.970 USD -409,839 763.78 Profit of 55,305 on sale
2025-01-31 BUY 56 672.980 688.000 686.498 USD 38,444 765.18
2025-01-30 BUY 7 683.080 689.620 688.966 USD 4,823 766.46
2025-01-29 BUY 119 687.270 697.570 696.540 USD 82,888 767.72
2025-01-28 BUY 42 686.330 690.300 689.903 USD 28,976 769.03
2025-01-27 BUY 42 684.710 698.450 697.076 USD 29,277 770.41
2025-01-24 BUY 42 675.790 693.840 692.035 USD 29,065 771.99
2025-01-23 BUY 119 694.640 696.190 696.035 USD 82,828 773.30
2025-01-22 BUY 70 680.030 699.880 697.895 USD 48,853 774.91
2025-01-21 BUY 413 687.800 692.930 692.417 USD 285,968 776.44
2025-01-17 BUY 84 681.580 707.480 704.890 USD 59,211 779.89
2025-01-15 BUY 42 703.430 712.600 711.683 USD 29,891 782.97
2025-01-13 BUY 119 716.900 717.370 717.323 USD 85,361 786.07
2025-01-10 BUY 91 696.880 724.730 721.945 USD 65,697 787.85
2024-12-31 BUY 21 712.330 713.000 712.933 USD 14,972 793.43
2024-12-30 BUY 28 702.590 708.970 708.332 USD 19,833 795.45
2024-12-27 BUY 133 712.400 718.990 718.331 USD 95,538 797.34
2024-12-23 BUY 42 715.130 718.190 717.884 USD 30,151 803.33
2024-12-20 BUY 4,328 701.850 717.610 716.034 USD 3,098,995 805.87
2024-12-19 BUY 48 708.250 714.050 713.470 USD 34,247 808.37
2024-12-17 BUY 36 740.010 744.800 744.321 USD 26,796 812.75
2024-12-16 BUY 12 724.870 739.390 737.938 USD 8,855 815.19
2024-12-13 BUY 20 731.300 740.170 739.283 USD 14,786 817.59
2024-12-11 BUY 12 773.000 781.320 780.488 USD 9,366 818.90
2024-12-10 BUY 8 778.500 791.490 790.191 USD 6,322 820.13
2024-12-09 BUY 8 788.000 800.990 799.691 USD 6,398 821.13
2024-12-05 SELL -24 767.900 768.020 768.008 USD -18,432 824.34 Profit of 1,352 on sale
2024-12-04 BUY 4 754.260 756.130 755.943 USD 3,024 826.76
2024-12-02 BUY 16 762.340 763.890 763.735 USD 12,220 832.00
2024-11-29 BUY 72 750.220 754.510 754.081 USD 54,294 835.15
2024-11-27 BUY 16 754.870 762.160 761.431 USD 12,183 841.84
2024-11-26 BUY 40 753.030 754.180 754.065 USD 30,163 845.70
2024-11-25 BUY 496 749.510 757.860 757.025 USD 375,484 850.07
2024-11-22 BUY 12 738.000 751.400 750.060 USD 9,001 855.41
2024-11-21 BUY 12 744.500 757.560 756.254 USD 9,075 860.96
2024-11-20 BUY 52 743.350 750.690 749.956 USD 38,998 867.15
2024-11-19 SELL -52 744.600 758.600 757.200 USD -39,374 873.95 Profit of 6,071 on sale
2024-11-18 BUY 240 762.000 762.700 762.630 USD 183,031 880.54
2024-11-12 BUY 48 821.000 831.000 830.000 USD 39,840 884.26
2024-11-11 BUY 12 825.680 834.420 833.546 USD 10,003 888.17
2024-11-08 BUY 48 828.420 830.730 830.499 USD 39,864 892.43
2024-11-07 BUY 80 824.480 832.530 831.725 USD 66,538 897.66
2024-11-06 BUY 36 816.650 844.510 841.724 USD 30,302 904.41
2024-11-05 BUY 8 829.430 836.630 835.910 USD 6,687 911.23
2024-11-04 BUY 40 828.840 852.010 849.693 USD 33,988 919.47
2024-11-01 BUY 20 843.600 862.000 860.160 USD 17,203 927.90
2024-10-31 SELL -184 838.200 883.150 878.655 USD -161,673 939.11 Profit of 11,124 on sale
2024-10-30 BUY 12 922.790 935.860 934.553 USD 11,215 941.44
2024-10-29 BUY 76 927.330 932.380 931.875 USD 70,823 943.79
2024-10-25 BUY 16 933.020 943.830 942.749 USD 15,084 950.28
2024-10-24 BUY 12 928.900 952.020 949.708 USD 11,396 957.41
2024-10-22 BUY 24 962.340 972.750 971.709 USD 23,321 968.50
2024-10-21 BUY 20 968.500 991.240 988.966 USD 19,779 0.00
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-03	BUY	40	744.225	720.140	722.549	USD 28,902	650.44
2025-12-01	BUY	160	779.840	748.210	751.373	USD 120,220	649.62
2025-11-27	BUY	180			784.610*		649.04
2025-11-21	BUY	20			755.900*		648.58
2025-11-11	SELL	-10	676.330	651.410	653.902	USD -6,539	647.14 Loss of -68 on sale
2025-11-07	BUY	70			657.530*		647.05
2025-11-05	SELL	-680	646.895	628.000	629.890	USD -428,325	647.07 Profit of 11,682 on sale
2025-10-29	SELL	-538	652.910	659.980	659.273	USD -354,689	647.10 Loss of -6,550 on sale
2025-10-24	SELL	-110	577.950	582.700	582.225	USD -64,045	647.68 Profit of 7,200 on sale
2025-10-23	SELL	-20	575.690	584.000	583.169	USD -11,663	648.02 Profit of 1,297 on sale
2025-10-22	BUY	30	584.740	588.710	588.313	USD 17,649	648.32
2025-10-20	SELL	-350	576.770	582.650	582.062	USD -203,722	648.99 Profit of 23,425 on sale
2025-10-16	SELL	-50	569.170	589.080	587.089	USD -29,354	649.37 Profit of 3,114 on sale
2025-10-15	SELL	-125	576.420	584.870	584.025	USD -73,003	649.73 Profit of 8,213 on sale
2025-10-03	BUY	40	600.000	618.010	616.209	USD 24,648	650.66
2025-10-02	SELL	-400	600.000	605.410	604.869	USD -241,948	650.91 Profit of 18,417 on sale
2025-10-01	SELL	-383	599.940	615.390	613.845	USD -235,103	651.16 Profit of 14,293 on sale
2025-09-30	SELL	-10	562.270	574.040	572.863	USD -5,729	651.61 Profit of 787 on sale
2025-09-29	SELL	-132	560.750	564.910	564.494	USD -74,513	652.06 Profit of 11,559 on sale
2025-09-26	SELL	-10	563.900	564.610	564.539	USD -5,645	652.50 Profit of 880 on sale
2025-09-25	BUY	130	555.510	579.000	576.651	USD 74,965	652.99
2025-09-24	SELL	-88	576.980	577.980	577.880	USD -50,853	653.38 Profit of 6,644 on sale
2025-09-18	BUY	20	598.710	600.000	599.871	USD 11,997	653.66
2025-08-18	BUY	18	573.910	585.000	583.891	USD 10,510	655.26
2025-08-12	SELL	-10	556.550	562.740	562.121	USD -5,621	657.16 Profit of 950 on sale
2025-07-31	SELL	-411	545.460	558.130	556.863	USD -228,871	657.75 Profit of 41,467 on sale
2025-07-29	BUY	11	558.150	559.610	559.464	USD 6,154	658.85
2025-07-23	SELL	-30	572.390	576.700	576.269	USD -17,288	660.39 Profit of 2,524 on sale
2025-07-22	SELL	-60	560.930	563.000	562.793	USD -33,768	660.94 Profit of 5,889 on sale
2025-07-21	SELL	-20	545.530	552.980	552.235	USD -11,045	661.58 Profit of 2,187 on sale
2025-07-15	SELL	-20	547.960	574.750	572.071	USD -11,441	662.86 Profit of 1,816 on sale
2025-07-14	SELL	-50	570.590	575.130	574.676	USD -28,734	663.38 Profit of 4,435 on sale
2025-07-11	SELL	-30	567.740	568.460	568.388	USD -17,052	663.93 Profit of 2,866 on sale
2025-07-10	SELL	-120	559.760	566.370	565.709	USD -67,885	664.52 Profit of 11,858 on sale
2025-07-09	SELL	-40	552.580	558.380	557.800	USD -22,312	665.17 Profit of 4,295 on sale
2025-07-08	SELL	-130	547.750	559.460	558.289	USD -72,578	665.84 Profit of 13,982 on sale
2025-07-03	SELL	-170	547.360	555.000	554.236	USD -94,220	667.99 Profit of 19,338 on sale
2025-07-02	SELL	-31	547.740	551.500	551.124	USD -17,085	668.70 Profit of 3,645 on sale
2025-06-30	BUY	446	525.000	526.080	525.972	USD 234,584	669.56
2025-06-27	SELL	-490	521.000	531.210	530.189	USD -259,793	670.45 Profit of 68,726 on sale
2025-06-25	BUY	10	520.290	525.630	525.096	USD 5,251	672.26
2025-06-24	SELL	-370	522.270	527.450	526.932	USD -194,965	673.18 Profit of 54,110 on sale
2025-06-23	SELL	-10	511.920	516.180	515.754	USD -5,158	674.17 Profit of 1,584 on sale
2025-06-20	BUY	5,426	509.720	521.310	520.151	USD 2,822,339	675.18
2025-06-18	SELL	-42	513.580	519.170	518.611	USD -21,782	677.20 Profit of 6,661 on sale
2025-06-17	SELL	-77	508.860	523.010	521.595	USD -40,163	678.26 Profit of 12,063 on sale
2025-06-11	SELL	-21	518.600	528.370	527.393	USD -11,075	680.27 Profit of 3,210 on sale
2025-06-10	SELL	-49	523.530	529.990	529.344	USD -25,938	681.28 Profit of 7,445 on sale
2025-06-06	SELL	-14	493.220	499.880	499.214	USD -6,989	683.56 Profit of 2,581 on sale
2025-06-05	SELL	-119	483.070	491.770	490.900	USD -58,417	684.87 Profit of 23,083 on sale
2025-06-02	SELL	-567	490.810	502.560	501.385	USD -284,285	688.81 Profit of 106,271 on sale
2025-05-30	SELL	-126	490.280	519.780	516.830	USD -65,121	690.14 Profit of 21,838 on sale
2025-05-29	SELL	-14	605.390	605.730	605.696	USD -8,480	690.72 Profit of 1,190 on sale
2025-05-27	SELL	-14	603.260	608.170	607.679	USD -8,508	691.99 Profit of 1,180 on sale
2025-05-23	SELL	-21	588.340	591.640	591.310	USD -12,418	693.43 Profit of 2,145 on sale
2025-05-16	SELL	-105	594.320	595.190	595.103	USD -62,486	696.74 Profit of 10,672 on sale
2025-05-15	SELL	-21	584.990	585.260	585.233	USD -12,290	697.55 Profit of 2,359 on sale
2025-05-13	SELL	-7	574.160	575.050	574.961	USD -4,025	699.39 Profit of 871 on sale
2025-05-12	SELL	-49	575.630	577.990	577.754	USD -28,310	700.30 Profit of 6,005 on sale
2025-05-09	SELL	-42	527.780	552.840	550.334	USD -23,114	701.59 Profit of 6,353 on sale
2025-05-08	SELL	-203	547.670	552.570	552.080	USD -112,072	702.75 Profit of 30,586 on sale
2025-05-07	SELL	-14	560.930	568.130	567.410	USD -7,944	703.82 Profit of 1,910 on sale
2025-05-06	BUY	8	558.520	606.870	602.035	USD 4,816	704.93
2025-05-01	BUY	266	590.000	593.930	593.537	USD 157,881	707.40
2025-04-30	BUY	147	598.760	600.200	600.056	USD 88,208	708.25
2025-04-29	SELL	-28	568.910	579.980	578.873	USD -16,208	709.36 Profit of 3,654 on sale
2025-04-28	SELL	-35	610.860	614.830	614.433	USD -21,505	710.15 Profit of 3,350 on sale
2025-04-25	BUY	14	602.640	602.790	602.775	USD 8,439	711.01
2025-04-24	SELL	-7	599.760	601.280	601.128	USD -4,208	711.92 Profit of 776 on sale
2025-04-22	SELL	-938	585.490	587.100	586.939	USD -550,549	713.99 Profit of 119,173 on sale
2025-04-17	SELL	-427	563.160	564.210	564.105	USD -240,873	717.84 Profit of 65,644 on sale
2025-04-16	BUY	14	549.280	561.830	560.575	USD 7,848	719.28
2025-04-15	BUY	14	557.910	575.200	573.471	USD 8,029	720.67
2025-04-10	SELL	-441	546.390	571.990	569.430	USD -251,119	725.01 Profit of 68,610 on sale
2025-04-09	BUY	35	576.720	580.730	580.329	USD 20,312	726.33
2025-04-08	BUY	7	556.810	586.030	583.108	USD 4,082	727.86
2025-04-07	BUY	126	572.780	591.540	589.664	USD 74,298	729.27
2025-04-04	BUY	77	573.450	612.990	609.036	USD 46,896	730.70
2025-04-02	BUY	49	625.600	628.000	627.760	USD 30,760	731.67
2025-04-01	BUY	553	617.000	641.240	638.816	USD 353,265	732.74
2025-03-31	BUY	21	634.230	640.720	640.071	USD 13,441	733.67
2025-03-25	BUY	7	634.140	662.570	659.727	USD 4,618	737.47
2025-03-21	BUY	578	658.480	661.000	660.748	USD 381,912	739.02
2025-03-20	BUY	14	662.620	674.830	673.609	USD 9,431	739.80
2025-03-18	BUY	35	664.960	678.270	676.939	USD 23,693	741.26
2025-03-17	BUY	7	678.420	679.830	679.689	USD 4,758	741.92
2025-03-13	SELL	-420	680.610	698.950	697.116	USD -292,789	743.37 Profit of 19,426 on sale
2025-03-12	BUY	84	689.500	712.460	710.164	USD 59,654	743.95
2025-03-11	BUY	84	718.160	747.700	744.746	USD 62,559	744.23
2025-03-07	BUY	28	707.510	729.750	727.526	USD 20,371	744.63
2025-03-06	BUY	98	698.440	701.000	700.744	USD 68,673	745.15
2025-03-05	BUY	532	687.150	692.790	692.226	USD 368,264	745.81
2025-03-04	BUY	28	675.490	697.460	695.263	USD 19,467	746.62
2025-03-03	BUY	35	684.870	704.640	702.663	USD 24,593	747.33
2025-02-28	BUY	70	698.740	708.580	707.596	USD 49,532	747.91
2025-02-27	BUY	63	702.780	721.000	719.178	USD 45,308	748.44
2025-02-26	SELL	-35	706.940	721.410	719.963	USD -25,199	748.94 Profit of 1,014 on sale
2025-02-25	SELL	-7	723.470	739.000	737.447	USD -5,162	749.25 Profit of 83 on sale
2025-02-24	BUY	7	713.250	725.000	723.825	USD 5,067	749.70
2025-02-20	SELL	-91	696.020	703.140	702.428	USD -63,921	751.00 Profit of 4,420 on sale
2025-02-19	BUY	28	685.660	688.670	688.369	USD 19,274	751.84
2025-02-18	BUY	28	680.000	689.950	688.955	USD 19,291	752.77
2025-02-13	BUY	798	674.270	677.690	677.348	USD 540,524	755.97
2025-02-12	BUY	238	663.860	670.980	670.268	USD 159,524	757.24
2025-02-11	BUY	196	665.460	680.790	679.257	USD 133,134	758.51
2025-02-07	BUY	21	710.000	731.420	729.278	USD 15,315	760.18
2025-02-06	BUY	280	722.070	734.270	733.050	USD 205,254	760.73
2025-02-05	BUY	140	716.720	729.250	727.997	USD 101,920	761.38
2025-02-04	BUY	105	697.050	709.980	708.687	USD 74,412	762.34
2025-02-03	SELL	-609	666.850	673.650	672.970	USD -409,839	763.78 Profit of 55,305 on sale
2025-01-31	BUY	56	672.980	688.000	686.498	USD 38,444	765.18
2025-01-30	BUY	7	683.080	689.620	688.966	USD 4,823	766.46
2025-01-29	BUY	119	687.270	697.570	696.540	USD 82,888	767.72
2025-01-28	BUY	42	686.330	690.300	689.903	USD 28,976	769.03
2025-01-27	BUY	42	684.710	698.450	697.076	USD 29,277	770.41
2025-01-24	BUY	42	675.790	693.840	692.035	USD 29,065	771.99
2025-01-23	BUY	119	694.640	696.190	696.035	USD 82,828	773.30
2025-01-22	BUY	70	680.030	699.880	697.895	USD 48,853	774.91
2025-01-21	BUY	413	687.800	692.930	692.417	USD 285,968	776.44
2025-01-17	BUY	84	681.580	707.480	704.890	USD 59,211	779.89
2025-01-15	BUY	42	703.430	712.600	711.683	USD 29,891	782.97
2025-01-13	BUY	119	716.900	717.370	717.323	USD 85,361	786.07
2025-01-10	BUY	91	696.880	724.730	721.945	USD 65,697	787.85
2024-12-31	BUY	21	712.330	713.000	712.933	USD 14,972	793.43
2024-12-30	BUY	28	702.590	708.970	708.332	USD 19,833	795.45
2024-12-27	BUY	133	712.400	718.990	718.331	USD 95,538	797.34
2024-12-23	BUY	42	715.130	718.190	717.884	USD 30,151	803.33
2024-12-20	BUY	4,328	701.850	717.610	716.034	USD 3,098,995	805.87
2024-12-19	BUY	48	708.250	714.050	713.470	USD 34,247	808.37
2024-12-17	BUY	36	740.010	744.800	744.321	USD 26,796	812.75
2024-12-16	BUY	12	724.870	739.390	737.938	USD 8,855	815.19
2024-12-13	BUY	20	731.300	740.170	739.283	USD 14,786	817.59
2024-12-11	BUY	12	773.000	781.320	780.488	USD 9,366	818.90
2024-12-10	BUY	8	778.500	791.490	790.191	USD 6,322	820.13
2024-12-09	BUY	8	788.000	800.990	799.691	USD 6,398	821.13
2024-12-05	SELL	-24	767.900	768.020	768.008	USD -18,432	824.34 Profit of 1,352 on sale
2024-12-04	BUY	4	754.260	756.130	755.943	USD 3,024	826.76
2024-12-02	BUY	16	762.340	763.890	763.735	USD 12,220	832.00
2024-11-29	BUY	72	750.220	754.510	754.081	USD 54,294	835.15
2024-11-27	BUY	16	754.870	762.160	761.431	USD 12,183	841.84
2024-11-26	BUY	40	753.030	754.180	754.065	USD 30,163	845.70
2024-11-25	BUY	496	749.510	757.860	757.025	USD 375,484	850.07
2024-11-22	BUY	12	738.000	751.400	750.060	USD 9,001	855.41
2024-11-21	BUY	12	744.500	757.560	756.254	USD 9,075	860.96
2024-11-20	BUY	52	743.350	750.690	749.956	USD 38,998	867.15
2024-11-19	SELL	-52	744.600	758.600	757.200	USD -39,374	873.95 Profit of 6,071 on sale
2024-11-18	BUY	240	762.000	762.700	762.630	USD 183,031	880.54
2024-11-12	BUY	48	821.000	831.000	830.000	USD 39,840	884.26
2024-11-11	BUY	12	825.680	834.420	833.546	USD 10,003	888.17
2024-11-08	BUY	48	828.420	830.730	830.499	USD 39,864	892.43
2024-11-07	BUY	80	824.480	832.530	831.725	USD 66,538	897.66
2024-11-06	BUY	36	816.650	844.510	841.724	USD 30,302	904.41
2024-11-05	BUY	8	829.430	836.630	835.910	USD 6,687	911.23
2024-11-04	BUY	40	828.840	852.010	849.693	USD 33,988	919.47
2024-11-01	BUY	20	843.600	862.000	860.160	USD 17,203	927.90
2024-10-31	SELL	-184	838.200	883.150	878.655	USD -161,673	939.11 Profit of 11,124 on sale
2024-10-30	BUY	12	922.790	935.860	934.553	USD 11,215	941.44
2024-10-29	BUY	76	927.330	932.380	931.875	USD 70,823	943.79
2024-10-25	BUY	16	933.020	943.830	942.749	USD 15,084	950.28
2024-10-24	BUY	12	928.900	952.020	949.708	USD 11,396	957.41
2024-10-22	BUY	24	962.340	972.750	971.709	USD 23,321	968.50
2024-10-21	BUY	20	968.500	991.240	988.966	USD 19,779	0.00

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of REGN

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	208,659	1,635	312,812	66.7%
2025-09-18	236,485	3,679	387,519	61.0%
2025-09-17	229,191	716	370,895	61.8%
2025-09-16	173,632	584	271,020	64.1%
2025-09-15	204,491	251	334,496	61.1%
2025-09-12	117,504	33	222,760	52.7%
2025-09-11	125,478	3,137	286,516	43.8%
2025-09-10	195,068	481	339,885	57.4%
2025-09-09	129,168	994	274,520	47.1%
2025-09-08	250,895	396	527,062	47.6%
2025-09-05	170,149	290	289,566	58.8%
2025-09-04	188,227	2,103	360,619	52.2%
2025-09-03	185,679	344	438,111	42.4%
2025-09-02	191,954	138	476,288	40.3%
2025-08-29	133,226	685	236,726	56.3%
2025-08-28	116,560	2,177	256,675	45.4%
2025-08-27	113,719	465	243,836	46.6%
2025-08-26	210,376	450	400,199	52.6%
2025-08-25	149,130	68	363,377	41.0%
2025-08-22	211,822	3,244	701,770	30.2%
2025-08-21	257,492	3,416	446,439	57.7%
2025-08-20	327,738	572	559,133	58.6%
2025-08-19	118,472	2,191	324,311	36.5%
2025-08-18	146,282	388	277,909	52.6%
2025-08-15	209,923	3,375	441,752	47.5%
2025-08-14	157,569	3,623	429,327	36.7%
2025-08-13	111,342	233	362,786	30.7%
2025-08-12	117,647	171	310,775	37.9%
2025-08-11	129,513	2,676	284,757	45.5%
2025-08-08	128,559	1,038	431,841	29.8%
2025-08-07	166,648	1,560	352,877	47.2%
2025-08-06	176,311	624	397,089	44.4%
2025-08-05	154,257	115	353,744	43.6%
2025-08-04	200,758	1,913	409,897	49.0%
2025-08-01	349,775	3,745	728,720	48.0%
2025-07-31	222,350	476	549,344	40.5%
2025-07-30	106,839	1,689	231,761	46.1%
2025-07-29	149,359	276	292,667	51.0%
2025-07-28	103,687	1,380	245,287	42.3%
2025-07-25	103,783	556	259,069	40.1%
2025-07-24	156,974	2,397	291,677	53.8%
2025-07-23	168,734	1,708	355,372	47.5%
2025-07-22	116,324	617	304,880	38.2%
2025-07-21	98,482	900	250,107	39.4%
2025-07-18	183,174	1,051	391,909	46.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.